朱正保、男、苏州大学优秀青年****（讲师）
电话：**
电子邮箱:zbzhu@suda.edu.cn
通讯地址：苏州工业园区仁爱路199号苏州大学一期医学楼医学部公共卫生学院401号1404A室, 邮编215123
个人简介：
朱正保（ZhengbaoZhu），医学博士，苏州大学优秀青年****、讲师。
学习经历
2010.9-2015.6 苏州大学，预防医学，医学学士
2018.8-2019.12 美国杜兰大学，流行病学，联合培养博士
2015.9-2020.6 苏州大学，流行病与卫生统计学，医学博士
工作经历
2020.07- 苏州大学，医学部公共卫生学院，苏州大学优秀青年****（讲师）
目前学术任职：
1.江苏省预防医学会慢性非传染性疾病预防与控制专业委员会委员（2020年12月-2025年12月）
2.江苏省预防医学会流行病学专业委员会青年委员（2020年10月-2025年10月）
3.苏州市预防医学会流行病学专业委员会委员（2020年9月-2023年1月）
4.美国心脏协会会员（2018年10月-）
5.Neurology, International journal of obesity, Clinical Interventions in Aging, Biomedical and Environmental Sciences,International journal of hypertension, Neurology: Clinical Practice等多个杂志的审稿人。
研究方向：
1. 心脑血管流行病学
2. 遗传流行病学
科研项目：
1.苏州大学，苏州大学人才引进启动经费，2020.07-2022.12，40万，主持
2.国家自然科学基金委员会，重点国际（地区）合作研究项目，，缺血性脑卒中基因与环境交互作用及代谢组学研究、2021/01-2025/12，248万元，第7参与人。
代表性论文：
在ATVB、Neurology、Stroke、Clinical Chemistry、Journal of Neuroinflammation、Atherosclerosis等杂志发表SCI论文40余篇，其中以第一作者发表论文20篇。按照2020年中科院期刊分区升级版，其中7篇为中科院1区Top，3篇为中科院2区Top，2篇为中科院2区。
1.Zhu Zhengbao,Guo D, Zhong C, Wang A, Xie X, Xu T, et al. Serum Dkk-1 (Dickkopf-1) is a potential biomarker in the prediction of clinical outcomes among patients with acute ischemic stroke. Arterioscler Thromb Vasc Biol. 2019;39(2):285-293.
2.Zhu Zhengbao,Xu T, Guo D, Huangfu X, Zhong C, Yang J, et al. Serum hepatocyte growth factor is probably associated with 3-month prognosis of acute ischemic stroke. Stroke. 2018;49(2):377-383.
3.Zhu Zhengbao,Guo D, Zhong C, Wang A, Xu T, Peng Y, et al. Serum dickkopf-3 is associated with death and vascular events after ischemic stroke: An observational study from CATIS. Journal of Neuroinflammation. 2020;17(1):12.
4.Zhong C, Zhu Zhengbao (co-first), Wang A, Xu T, Bu X, Peng H, et al. Multiple biomarkers covering distinct pathways for predicting outcomes after ischemic stroke. Neurology. 2019;92(4):e295-e304.
5.Guo D, Zhu Zhengbao (co-first), Zhong C, Peng H, Wang A, Xu T, et al. Increased serum netrin-1 is associated with improved prognosis of ischemic stroke. Stroke. 2019;50(4):845-852.
6.Guo D, Zhu Zhengbao (co-first), Xu T, Zhong C, Wang A, Xie X, et al. Plasma S100A8/A9 concentrations and clinical outcomes of ischemic stroke in 2 independent multicenter cohorts. Clin Chem. 2020;66(5):706-717.
7. Guo D, Zhu Zhengbao (co-first), Zhong C, Wang A, Xie X, Xu T, et al. Prognostic metrics associated with inflammation and atherosclerosis signaling evaluate the burden of adverse clinical outcomes in ischemic stroke patients. Clin Chem. 2020;66(11):1434-1443.
8.Zhu Zhengbao, Zhong C, Guo D, Bu X, Xu T, Guo L, et al. Multiple biomarkers covering several pathways improve predictive ability for cognitive impairment among ischemic stroke patients with elevated blood pressure. Atherosclerosis. 2019;287:30-37.
9.Zhu Zhengbao, Zhong C, Xu T, Wang A, Peng Y, Xu T, et al. Prognostic significance of serum cystatin c in acute ischemic stroke patients according to lipid component levels. Atherosclerosis. 2018;274:146-151.
10.Zhu Zhengbao, Zhong C, Xu T, Wang A, Peng Y, Xu T, et al. Effect of renal function status on the prognostic value of heart rate in acute ischemic stroke patients. Atherosclerosis. 2017;263:1-6.
11.Zhu Zhengbao, Zhang Q, Peng H, Zhong C, Liu Y, Huangfu X, et al. Association between plasma proANP and hyperuricemia in Chinese Han women: A cross-sectional study. Clin Chem Lab Med. 2017;55(8):1160-1167.
12.You T, Zhu Zhengbao (co-first), Zheng X, Zeng N, Hu S, Liu Y, et al. Serum semaphorin 7A is associated with the risk of acute atherothrombotic stroke. J Cell Mol Med. 2019;23:2901-2906.
13.Zhu Zhengbao, Wang A, Guo D, Bu X, Xu T, Zhong C, et al. Association between serum hepatocyte growth factor and prognosis of ischemic stroke: the role of blood lipid status. Nutr Metab Cardiovasc Dis. 2020;30(3):492-499.
14.Zhu Zhengbao, Zhang Q, Peng H, Zhong C, Guo D, Huangfu X, et al. Predictive value of serum soluble corin in the risk of hyperglycemia: A population-based prospective cohort study in China. Clin Chim Acta. 2018;479:138-143.
15.Zhu Zhengbao, Zhang Q, Peng H, Zhong C, Liu Y, Huangfu X, et al. Plasma proANP1-98 levels are positively associated with central obesity: A cross-sectional study in a general population of China. Clin Chim Acta. 2017;469:26-30.
16.Zhu Zhengbao, Yang J, Zhong C, Xu T, Wang A, Bu X, et al. Abnormal glucose regulation, hypoglycemic treatment during hospitalization and prognosis of acute ischemic stroke. J Neurol Sci. 2017;379:177-182.
17.Zhu Zhengbao, Huangfu X, Zhong C, Zhou Y, Tian Y, Buren B, et al. Combined effects of family history of cardiovascular disease and serum C-reactive protein level on the risk of stroke: A 9.2-year prospective study among Mongolians in China. Biomed Environ Sci. 2017;30(9):632-640.
18.Guo D,Zhu Zhengbao (co-first), Zhong C, Bu X, Chen L, Xu T, et al. Serum cystatin C levels are negatively correlated with post-stroke cognitive dysfunction. Neural Regen Res. 2020;15(5):922-928.
19.Zhu Zhengbao, Chen L, Guo D, Zhong C, Wang A, Bu X, et al. Serum rheumatoid factor levels at acute phase of ischemic stroke are associated with poststroke cognitive impairment. J Stroke Cerebrovasc Dis. 2019;28(4):1133-1140.
20.He Y, Zhu Zhengbao (co-first), Guo D, Zhang H, Zheng X, Zeng N, et al. The U-shaped relationship between serum methylene tetrahydrofolate reductase and large-artery atherosclerotic stroke. Curr Neurovasc Res. 2019;16(1):82-88.
21.朱正保, 仲崇科, 张凯欣, 等. 中国内地新型冠状病毒肺炎流行趋势分析 [J]. 中华预防医学杂志. 2020. DOI: 10.3760/cma.j.cn112-00163.
承担的教学情况：
1.承担临床医学本科生《流行病学》和《循证医学》等课程的教学工作；

荣誉奖励:
1.朱正保（7/9） 可溶性corin在高血压及心血管病社区防控中的应用，苏州市医学会, 苏州市医学会医学科技奖（二等奖）, 2019 (张秋; 彭浩; 张永红; 张欢; 胡伟东; 金建华; 朱正保; 周伟华; 石际俊).
2.朱正保(1/1) 博士研究生国家奖学金，中华人民共和国教育部，2018
3.朱正保(1/1) 国家留学基金委公派留学奖学金，国家留学基金管理委员会，2018
4.朱正保(1/1) 博士研究生国家奖学金，中华人民共和国教育部，2019
（以上内容系教师个人提供）